These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [S-aminocaproic acid and hindrance to ejaculation]. Martínez Sánchez G; Pedros C Aten Primaria; 1998 Jun; 22(1):63-4. PubMed ID: 9741164 [No Abstract] [Full Text] [Related]
23. Acute delirious state after epsilon-aminocaproic acid. Wysenbeek AJ; Sella A; Vardi M; Yeshurun D Lancet; 1978 Jan; 1(8057):221. PubMed ID: 74653 [No Abstract] [Full Text] [Related]
24. Aminocaproic acid in the control of haemorrhage after prostatectomy. Safety of aminocaproic acid--a controlled trial. Vinnicombe J; Shuttleworth KE Lancet; 1966 Jan; 1(7431):232-4. PubMed ID: 4159071 [No Abstract] [Full Text] [Related]
25. Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Britt CW; Light RR; Peters BH; Schochet SS Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431 [TBL] [Abstract][Full Text] [Related]
26. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Galassi G; Gibertoni M; Corradini L; Colombo A Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249 [TBL] [Abstract][Full Text] [Related]
32. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms. Burchiel KJ; Schmer G J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112 [TBL] [Abstract][Full Text] [Related]
33. Epsilon aminocaproic acid (EACA) myopathy. Lane RJ; McLelland NJ; Martin AM; Mastaglia FL Postgrad Med J; 1979; 55(642):282-5. PubMed ID: 471867 [TBL] [Abstract][Full Text] [Related]
34. Epsilon-aminocaproic acid myopathy. Report of a case and literature review. Vanneste JA; van Wijngaarden GK Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311 [TBL] [Abstract][Full Text] [Related]
35. Aminocaproic acid. Use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia. Gardner FH; Helmer RE JAMA; 1980 Jan; 243(1):35-7. PubMed ID: 6965311 [TBL] [Abstract][Full Text] [Related]
36. Aminocaproic acid as a local hemostatic agent in epistaxis. Berkstein A Arch Otolaryngol; 1971 May; 93(5):456-7. PubMed ID: 5102971 [No Abstract] [Full Text] [Related]
37. The complications of therapy with epsilon-aminocaproic acid. Bergin JJ Med Clin North Am; 1966 Nov; 50(6):1669-78. PubMed ID: 5339196 [No Abstract] [Full Text] [Related]
38. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS]. WEISS M; YVER J; SAMAMA M; DUBOST C Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607 [No Abstract] [Full Text] [Related]
39. Aminocaproic acid myopathy. Swash M Br Med J; 1980 Aug; 281(6237):454. PubMed ID: 7427315 [No Abstract] [Full Text] [Related]
40. The effect of epsilon aminocaproic acid and tranexamic acid on thrombus size and strength in a simulated arterial aneurysm. Patterson RH; Harpel P J Neurosurg; 1971 Mar; 34(3):365-71. PubMed ID: 5547318 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]